Growing community of inventors

Cleveland Heights, OH, United States of America

Xiangxue Wang

Average Co-Inventor Count = 3.43

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 77

Xiangxue WangAnant Madabhushi (7 patents)Xiangxue WangVamsidhar Velcheti (6 patents)Xiangxue WangCristian Barrera (2 patents)Xiangxue WangJim F Martin (1 patent)Xiangxue WangYao Nie (1 patent)Xiangxue WangPranjal Vaidya (1 patent)Xiangxue WangQinle Ba (1 patent)Xiangxue WangMohammadhassan Izady Yazdanabadi (1 patent)Xiangxue WangSatarupa Mukherjee (1 patent)Xiangxue WangGerman Corredor Prada (1 patent)Xiangxue WangXiangxue Wang (8 patents)Anant MadabhushiAnant Madabhushi (107 patents)Vamsidhar VelchetiVamsidhar Velcheti (16 patents)Cristian BarreraCristian Barrera (3 patents)Jim F MartinJim F Martin (28 patents)Yao NieYao Nie (19 patents)Pranjal VaidyaPranjal Vaidya (7 patents)Qinle BaQinle Ba (1 patent)Mohammadhassan Izady YazdanabadiMohammadhassan Izady Yazdanabadi (1 patent)Satarupa MukherjeeSatarupa Mukherjee (1 patent)German Corredor PradaGerman Corredor Prada (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Case Western Reserve University (7 from 1,310 patents)

2. The Cleveland Clinic Foundation (2 from 1,039 patents)

3. Ventana Medical Systems, Inc. (1 from 514 patents)


8 patents:

1. 12424323 - Hybrid and accelerated ground-truth generation for duplex arrays

2. 11107583 - Sequential integration of adversarial networks with handcrafted features (SANwicH): identifying sites of prognostic significance for predicting cancer recurrence

3. 11055844 - Predicting response to immunotherapy using computer extracted features of cancer nuclei from hematoxylin and eosin (HandE) stained images of non-small cell lung cancer (NSCLC)

4. 10956795 - Predicting recurrence in early stage non-small cell lung cancer (NSCLC) using spatial arrangement of clusters of tumor infiltrating lymphocytes and cancer nuclei

5. 10902256 - Predicting response to immunotherapy using computer extracted features relating to spatial arrangement of tumor infiltrating lymphocytes in non-small cell lung cancer

6. 10846367 - Predicting recurrence in early stage non-small cell lung cancer (NSCLC) with integrated radiomic and pathomic features

7. 10078895 - Prediction of recurrence of non-small cell lung cancer with tumor infiltrating lymphocyte (TIL) graphs

8. 10049770 - Prediction of recurrence of non-small cell lung cancer

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/31/2025
Loading…